We are live on ! Find out more
MIFH

Migdal Insurance & Financial Holdings Portfolio holdings

AUM $15.6B
1-Year Est. Return 71.29%
This Fund
S&P 500
This Quarter Est. Return
+20.27%
1 Year Est. Return
+71.29%
3 Year Est. Return
+173.57%
5 Year Est. Return
+196.76%
10 Year Est. Return
+800.33%
AUM
$8.47B
AUM Growth
+$1.27B
Cap. Flow
+$26.3M
Cap. Flow %
0.31%
Top 10 Hldgs %
39.44%
Holding
764
New
106
Increased
151
Reduced
309
Closed
117

Sector Composition

Rank Sector Weight
1 Technology 21.75%
2 Financials 9.43%
3 Consumer Discretionary 9.03%
4 Communication Services 6.41%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LDOS icon
251
Leidos
LDOS
$17.6B
$323K ﹤0.01%
3,077
ADPT icon
252
Adaptive Biotechnologies
ADPT
$4.02B
$318K ﹤0.01%
+5,376
New +$277K
FLGT icon
253
Fulgent Genetics
FLGT
$515M
$314K ﹤0.01%
+6,031
New +$252K
PGEN icon
254
Precigen
PGEN
$2.45B
$310K ﹤0.01%
+30,360
New +$197K
ARWR icon
255
Arrowhead Research
ARWR
$12.3B
$309K ﹤0.01%
+4,022
New +$257K
PAYC icon
256
Paycom
PAYC
$9.52B
$308K ﹤0.01%
682
-21,942
-97% -$8.74M
RGNX icon
257
Regenxbio
RGNX
$720M
$308K ﹤0.01%
+6,789
New +$237K
CDNA icon
258
CareDx
CDNA
$2.45B
$304K ﹤0.01%
+4,194
New +$243K
VEEV icon
259
Veeva Systems
VEEV
$39.2B
$303K ﹤0.01%
1,112
-35,000
-97% -$9.81M
NSTG
260
DELISTED
NanoString Technologies, Inc.
NSTG
$302K ﹤0.01%
+4,509
New +$226K
COUP
261
DELISTED
Coupa Software Incorporated
COUP
$302K ﹤0.01%
892
-28,123
-97% -$8.7M
EDU icon
262
New Oriental
EDU
$8.49B
$299K ﹤0.01%
1,652
-145
-8% -$24.4K
RNG icon
263
RingCentral
RNG
$5.25B
$297K ﹤0.01%
785
-24,736
-97% -$7.69M
TWST icon
264
Twist Bioscience
TWST
$7.85B
$297K ﹤0.01%
+2,103
New +$233K
HDB icon
265
HDFC Bank
HDB
$119B
$295K ﹤0.01%
8,176
WDAY icon
266
Workday
WDAY
$43.3B
$292K ﹤0.01%
1,220
-38,313
-97% -$8.61M
NEO icon
267
NeoGenomics
NEO
$2.11B
$289K ﹤0.01%
+5,371
New +$243K
BPMC
268
DELISTED
Blueprint Medicines
BPMC
$288K ﹤0.01%
+2,564
New +$270K
KRYS icon
269
Krystal Biotech
KRYS
$9.85B
$288K ﹤0.01%
+4,796
New +$240K
MAR icon
270
Marriott International
MAR
$92.5B
$288K ﹤0.01%
2,181
-29,762
-93% -$3.4M
NTRA icon
271
Natera
NTRA
$45.5B
$288K ﹤0.01%
+2,892
New +$242K
SRPT icon
272
Sarepta Therapeutics
SRPT
$1.94B
$286K ﹤0.01%
+1,678
New +$249K
IONS icon
273
Ionis Pharmaceuticals
IONS
$9.39B
$285K ﹤0.01%
+5,048
New +$252K
MGTX icon
274
MeiraGTx Holdings
MGTX
$1.2B
$279K ﹤0.01%
+18,405
New +$260K
FLOT icon
275
iShares Floating Rate Bond ETF
FLOT
$10.5B
$276K ﹤0.01%
5,450

Similar funds

Migdal Insurance & Financial Holdings's Q4 2020 Portfolio in Review

As of Q4 2020, Migdal Insurance & Financial Holdings held 764 positions worth $8.47B, up 18% from $7.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Migdal Insurance & Financial Holdings's Q4 2020 filing shows 106 new, 151 increased, 309 reduced and 117 closed positions. Its largest new stake was State Street SPDR S&P Bank ETF: 4,235,863 shares worth $177M. The largest sale was KraneShares CSI China Internet ETF, an estimated $84.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Migdal Insurance & Financial Holdings's largest Q4 2020 buy was State Street SPDR S&P Bank ETF: 4,235,863 shares worth $177M.
  • Migdal Insurance & Financial Holdings added most to iShares Russell 2000 ETF in Q4 2020, an estimated $194M increase.
  • Migdal Insurance & Financial Holdings's biggest Q4 2020 reduction was KraneShares CSI China Internet ETF, cutting an estimated $84.5M.
  • Migdal Insurance & Financial Holdings fully exited Equinix in Q4 2020, selling an estimated $36M.
  • Migdal Insurance & Financial Holdings's ten largest holdings make up 39% of its $8.47B portfolio in Q4 2020.
  • Migdal Insurance & Financial Holdings opened 106 new positions and closed 117 in Q4 2020.
  • Migdal Insurance & Financial Holdings's portfolio value rose 18% quarter-over-quarter to $8.47B.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.